Chromosomal abnormality in hepatocellular carcinoma by comparative genomic hybridisation in Taiwan

European Journal of Cancer

Volumn 35, Issue 4, 1999, Pages 652-658

  Lin, Y W ^a   Sheu, J C ^b   Huang, G T ^b   Lee, H S ^b   Chen, C H ^b   Wang, J T ^b   Lee, P H ^b   Lu, F J ^b  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

Author keywords

Comparative genomic hybridization; DNA gain; DNA loss

Indexed keywords

DNA; FLUOROCHROME;

ADULT; AGED; ARTICLE; CHROMOSOME 13Q; CHROMOSOME 16Q; CHROMOSOME 17P; CHROMOSOME 17Q; CHROMOSOME 1Q; CHROMOSOME 4Q; CHROMOSOME 6P; CHROMOSOME 8P; CHROMOSOME 8Q; CHROMOSOME ABERRATION; CHROMOSOME LOSS; CLINICAL ARTICLE; COMPARATIVE GENOMIC HYBRIDIZATION; CONTROLLED STUDY; FEMALE; GENE AMPLIFICATION; HEPATITIS B VIRUS; HUMAN; HUMAN TISSUE; LIVER CARCINOGENESIS; LIVER CELL CARCINOMA; MALE; PRIORITY JOURNAL; VIRUS CARRIER;

ADULT; AGED; CARCINOMA, HEPATOCELLULAR; CHROMOSOME ABERRATIONS; DNA, NEOPLASM; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NUCLEIC ACID HYBRIDIZATION; TAIWAN;

EID: 0033119288     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0959-8049(98)00430-4     Document Type: Article

References (40)

1. Linsell DA, Higginson J. The geographic pathology of liver cell cancer. In Cameron HM, Linsell DA, Warwick GP, eds. Liver Cell Cancer. New York, Elsevier Science, 1976, 1-16.
2. Beasley R.P. Hepatitis B virus as the etiologic agent in hepatocellular carcinoma-epidemiologic considerations. Hepatology. 2:1982;21-26.
3. Chen DS. Hepatitis B virus infection, its sequelae, and prevention in Taiwan. In Okuda K, Ishak KG, eds. Neoplasms of the Liver. Tokyo, Springer, 1987, 71-80.
4. Sheu J.C., Huang G.T., Shih L.N., et al. Hepatitis C and B viruses in hepatitis B surface antigen negative hepatocellular carcinoma. Gastroenterology. 103:1992;1322-1327.
5. Sheu J.C., Huang G.T., Lee P.H., et al. Mutation of p53 gene in hepatocellular carcinoma in Taiwan. Cancer Res. 52:1992;6098-6100.
6. Schmandt R., Mills G.B. Genomic components of carcinogenesis. Clin. Chem. 39:1993;2375-2385.
7. Pitot H.C. The molecular biology of carcinogenesis. Cancer. 72:1993;962-970.
8. Strout M.P., Caligiuri M.A. Developments in cytogenetics and oncogenes in acute leukemia. Curr. Opin. Oncol. 9:1997;8-17.
9. Hermsen M.A., Meijer G.A., Baak J.P., et al. Comparative genomic hybridization: a new tool in cancer pathology. Human Pathol. 27:1996;342-349.
10. Teyssier J.R. The chromosomal analysis of human solid tumors. A triple challenge. Cancer Genet. Cytogenet. 37:1989;103-125.
11. Kallioniemi A., Kallioniemi O.P., Sudar D., et al. Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors. Science. 258:1992;818-821.
12. Fearon E.R., Vogelstein B. A genetic model for colorectal tumorigenesis. Cell. 61:1990;759-767.
13. Schwab M., Amler L.C. Amplification of cellular oncogenes: a predictor of clinical outcome in humans. Genes Chromosom. Cancer. 1:1990;181-193.
14. Wang H.P., Rogler C.E. Deletions in human chromosome arms 11p and 13q in primary hepatocellular carcinomas. Cytogenet. Cell. Genet. 48:1988;72-78.
15. Pasquinelli C., Garreau F., Bougueleret L., et al. Rearrangement of a common cellular DNA domain on chromosome 4 in human primary liver tumors. J. Virol. 62:1988;629-632.
16. Zhang W.D., Hirohashi S., Tsuda H., et al. Frequent loss of heterozygosity on chromosomes 16 and 4 in human hepatocellular carcinoma. Jpn. J. Cancer Res. 81:1990;108-111.
17. Tsuda H., Zhang W.D., Shimosato Y., et al. Allele loss on chromosome 16 associated with progression of human hepatocellular carcinoma. Proc. Natl. Acad. Sci. USA. 87:1990;6791-6794.
18. Urano Y., Watanabe K., Lin C.C., et al. Interstitial chromosomal deletion within 4q11-q13 in a human hepatoma cell line. Cancer Res. 51:1991;1460-1464.
19. Thibodeau S.N., Bren G., Schaid D. Microsatellite instability in cancer of the proximal colon. Science. 260:1993;816-819.
20. Yeh S.H., Chen P.J., Chen H.L., et al. Frequent genetic alterations at the distal region of chromosome 1p in human hepatocellular carcinomas. Cancer Res. 54:1994;4188-4192.
21. Miki Y., Swensen J., Shattuck-Eidens D., et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 266:1994;66-71.
22. Wooster R., Bignell G., Lancaster J.A., et al. Identification of the breast cancer susceptibility gene BRCA2. Nature. 378:1995;789-792.
23. Nagai H., Pineau P., Tiollais P., et al. Comprehensive allelotyping of human hepatocellular carcinoma. Oncogene. 14:1997;2927-2933.
24. Tarkkanen M., Karhu R., Kallioniemi A., et al. Gains and losses of DNA sequences in osteosarcomas by comparative genomic hybridization. Cancer Res. 55:1995;1334-1338.
25. Gordon K.B., Thompson C.T., Char D.H., et al. Comparative genomic hybridization in the detection of DNA copy number abnormalities in uveal melanoma. Cancer Res. 54:1994;4764-4768.
26. Kallioniemi A., Kallioniemi O.P., Piper J., et al. Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization. Proc. Natl. Acad. Sci. USA. 91:1994;2156-2160.
27. Ried T., Petersen I., Holtgreve Grez-H., et al. Mapping of multiple DNA gains and losses in primary small cell lung carcinomas by comparative genomic hybridization. Cancer Res. 54:1994;1801-1806.
28. Kallioniemi A., Kallioniemi O.P., Citro G., et al. Identification of gains and losses of DNA sequences in primary bladder cancer by comparative genomic hybridization. Genes, Chromosomes Cancer. 12:1995;213-219.
29. Iwabuchi H., Sakamoto M., Sakunaga H., et al. Genetic analysis of benign, low-grade, and high-grade ovarian tumors. Cancer Res. 55:1995;6172-6180.
30. Cher M.L., Bova G.S., Moore D.H., et al. Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping. Cancer Res. 56:1996;3091-3102.
31. Levin N.A., Brzoska P.M., Warnock M.L., et al. Identification of novel regions of altered DNA copy number in small cell lung tumors. Genes, Chromosomes & Cancer. 13:1995;175-185.
32. Becker S.A., Zhou Y.Z. Frequent loss of chromosome 8p in hepatitis B virus-positive hepatocellular carcinomas from China. Cancer Res. 56:1996;5092-5097.
33. Marchio A., Meddeb M., Pineau P., et al. Recurrent chromosomal abnormalities in hepatocellular carcinoma detected by comparative genomic hybridization. Genes, Chromosomes Cancer. 18:1997;59-65.
34. Tanner M.M., Trikkonen M., Kallioniemi A., et al. Increased copy number at 20q13 in breast cancer: defining the critical region and exclusion of candidate genes. Cancer Res. 54:1994;4257-4260.
35. Avet-Loiseau H., Andree-Ashley L.E., Moore D., et al. Molecular cytogenetic abnormalities in multiple myeloma and plasma cell leukemia measured using comparative genomic hybridization. Genes, Chromosomes Cancer. 19:1997;124-133.
36. Williams B.J., Jones E., Kozlowski J.M., et al. Comparative genomic hybridization and molecular cytogenetic characterization of two prostate cancer xenografts. Genes, Chromosomes Cancer. 18:1997;299-304.
37. Richter J., Jiang F., Gorog J.P., et al. Marked genetic differences between stage pTa and stage pT1 papillary bladder cancer detected by comparative genomic hybridization. Cancer Res. 57:1997;2860-2864.
38. Stagle B.L., Zhou Y-Z., Birchmerier W., et al. Deletion of the E-cadherin gene in hepatitis B virus-positive Chinese hepatocellular carcinomas. Hepatology. 18:1993;757-762.
39. Nose H., Imazeki F., Ohto M., et al. p53 gene mutations and 17p allelic deletions in hepatocellular carcinoma from Japan. Cancer. 72:1993;355-360.
40. Fujiwara Y., Ohata H., Kuroki T., et al. Isoaltion of a candidate gene on chromosome 8p21.3-22 that is homologous to an extracellular domain of the PDGF receptor beta gene. Oncogene. 10:1995;891-895.